Kids of three years in China to get their vaccine

Beijing : The drug maker on Tuesday affirmed that children of 3 years in China can get vaccinated on an emergency basis. It is the first country that has given permission to provide vaccination to the younger generation.

Since the outbreak of the pandemic, Beijing has nearly succeeded in bring the spread within its limit vaccine and has so far provide 77 million doses of the vaccine.

A spokesperson for Sinovac reported to AFP that it has got approval for trying it on kids.

The spokesperson stated, “In recent days, the Sinovac vaccine was approved for emergency use in three-to 17 –years-old.”

But the time when the children shall get the vaccine was left in the mist as it is the duty of the National Health Commission to decide ‘according to China’s current epidemic prevention and control needs and vaccine supply’.

The spokesperson commented that the company has already finished the early phase trials of the vaccine in kids and adolescents. The results are waiting to get published in the Lancet scientific journal in no time.

In the weekend, CCTV, state broadcaster exclaimed that an unnamed official from the State Council’s epidemic response task force has opined that the vaccines have already got a green signal so that it can be applied on kids and ‘the safety and effectiveness’ has been proved.

Sinopharm, a spokesperson for China’s major vaccine stated that the experts have pointed out to the efficacy of the vaccine on kids but didn’t mention whether it has got approval for usage or not.

According to the Chinese official, they are targeting to provide vaccination to 70 per cent of the 1.41 billion population by the end of the current year.

The World Health Organization (WHO) has given approval to both Sinopharm and Sinovac vaccines for emergency usage on people above the age of 18 years. Both the vaccines are administered in many other countries across the world.

WHO as of now didn’t approve the vaccination on children but the United States, Britain, Singapore and the European Union have already given approval to Pfizer-BioNTech vaccines on children aged 12 years.

On Tuesday, China registered 33 new positive cases that includes 19 in southern Guangdong provine, where the authorities are fighting against a local outbreak.